Article ; Online: Efficacy and safety of Xiaofeng powder (xiao feng san) in treating urticaria: A protocol for a systematic review and meta-analysis of randomized controlled trials.
2018 Volume 97, Issue 45, Page(s) e13039
Abstract: ... Xiaofeng powder (XFP) is one of the most commonly used Chinese herbal formula in China for urticaria ... of the study will provide evidence concerning the efficacy and safety of Xiaofeng Powder (xiao feng san ...
Abstract | Background: Urticaria is a common skin disease that has a high impact on a patient's daily life. Xiaofeng powder (XFP) is one of the most commonly used Chinese herbal formula in China for urticaria. However, due to the lack of systematic evaluations, its clinical efficacy remains controversial. This meta-analysis was performed to evaluate the effect and safety of XFP for urticaria. Methods: Seven databases, including Cochrane Central Register of Controlled Trials, PubMed, Embase, the Chinese National Knowledge Infrastructure (CNKI), the Chinese Scientific Journal Database (VIP), the Chinese Biomedical Literature Database (CBM), and the Wanfang Database. The period will be from their inception to September 2018. Randomized controlled trials of XFS used separately against conventional Western medicine therapy in patients with urticarial were included. After the methodologic quality was assessed and the valid data were extracted, RevMan 5.3 software was used for the final meta-analysis. Results: The results will provide evidence regarding the efficacy and safety of XFP in treating urticaria. Conclusion: The conclusion of our systematic review will provide evidence to judge whether XFP is an effective intervention for patient with urticaria. This systematic review will be disseminated in peer-reviewed publications. The results of the study will provide evidence concerning the efficacy and safety of Xiaofeng Powder (xiao feng san) in treating urticaria. Prospero registration number: PROSPERO CRD 42018087260. |
---|---|
MeSH term(s) | Clinical Protocols ; Drugs, Chinese Herbal/therapeutic use ; Humans ; Powders/therapeutic use ; Randomized Controlled Trials as Topic ; Systematic Reviews as Topic ; Treatment Outcome ; Urticaria/drug therapy |
Chemical Substances | Drugs, Chinese Herbal ; Powders ; xiaofeng granules |
Language | English |
Publishing date | 2018-11-07 |
Publishing country | United States |
Document type | Journal Article ; Meta-Analysis |
ZDB-ID | 80184-7 |
ISSN | 1536-5964 ; 0025-7974 |
ISSN (online) | 1536-5964 |
ISSN | 0025-7974 |
DOI | 10.1097/MD.0000000000013039 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.171: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.